For the quarter ending 2025-09-30, WHWK has $167,017K in assets. $9,849K in debts. $37,931K in cash and cash equivalents.
| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 37,931 | 144,936 | ||
| Short-term investments | 124,666 | 32,264 | ||
| Accounts receivable, net | 0 | 0 | ||
| Inventory | 0 | 0 | ||
| Prepaid expenses and other current assets | 2,439 | 1,471 | ||
| Total current assets | 165,036 | 178,671 | ||
| Property and equipment, gross | 377 | - | ||
| Accumulated depreciation | 373 | - | ||
| Property and equipment, net | 4 | 9 | ||
| Operating lease right-of-use assets | 0 | 0 | ||
| Other assets | 1,977 | 2,142 | ||
| Total assets | 167,017 | 180,822 | ||
| Accounts payable | 1,633 | 3,339 | ||
| Accrued liabilities | 8,216 | 5,417 | ||
| Operating lease liabilities, current portion | 0 | 0 | ||
| Total current liabilities | 9,849 | 8,756 | ||
| Operating lease liabilities, net of current portion | 0 | 0 | ||
| Other liabilities | 0 | 0 | ||
| Total liabilities | 9,849 | 8,756 | ||
| Common stock, 0.0001 par value 300,000,000 shares authorized 47,128,362 and 24,680,708 shares issued and outstanding as of september 30, 2025 and december 31, 2024, respectively | 4 | 4 | ||
| Additional paid-in capital | 487,024 | 484,306 | ||
| Accumulated other comprehensive income | 139 | 9 | ||
| Accumulated deficit | -329,999 | -312,253 | ||
| Total stockholders equity | 157,168 | 172,066 | ||
| Total liabilities and stockholders equity | 167,017 | 180,822 | ||
Whitehawk Therapeutics, Inc. (WHWK)
Whitehawk Therapeutics, Inc. (WHWK)